Definium Therapeutics Announces New Employee Inducement Grants
Definium Therapeutics granted inducement options to purchase an aggregate of 115,600 common shares to six newly hired non-executive employees. The options vest over a four-year period and were approved by the Compensation Committee on August 2, 2026, pursuant to NASDAQ Rule 5635(c)(4).
Key figures
- Shares granted
- 115600
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.